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Long-term outcomes for Transobturator Tension Free Vaginal Tapes in Women with 
Urodynamic Mixed Urinary Incontinence 
 
Abstract  
Aims: To assess the long-term patient reported outcomes following TO-TVT in women with 
urodynamic mixed urinary incontinence (MUI). 
Methods: A secondary analysis of the 9-year follow-up of the E-TOT study: 341 women 
with predominant SUI symptoms were randomised to undergo either inside-out or outside-in 
TO-TVT between April 2005 and April 2007. 48 women had preoperative Urodynamic MUI 
and were available for 9-year follow-up.  
Primary outcome was the patient-reported success rate defined as Very/Much improved on 
Patient’s Global Impression of Improvement (PGI-I). Secondary outcomes included impact 
on women’s quality of life; sexual function; OAB symptoms and late adverse events. 
Statistical analysis was performed using SPSS v.23.  
Results: 48 women completed the 9-year follow-up, with adjusted response rate of 63%. The 
success, based on the PGI-I was 64.6% (n=31), with a further 14.6% (n=7) who reported 
“improved”. There was no significant difference between groups (OR 1.11; 95%CI 0.33, 3.70; 
p>0.999). Clinically significant improvement in QoL was found in 85.3%.  Cure of urgency 
and UUI was reported by 35 and 41% while worsening was reported in 6.5% and 2.3% 
respectively. One patient reported chronic groin/leg pain. The small sample size and the 
sizeable loss to follow-up are limitations in this study. 
Conclusions: this is the first study to report the long-term outcomes of TO-TVT in women 
with urodynamic MUI; TO-TVT is associated with a good and sustained patient-reported 
success rate in women with MUI up to 9-years follow-up.  
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Introduction  
The unprecedented growth of the elderly population in the western world highlights the 
importance of studying the long-term outcomes of the interventions used for treatment of 
chronic conditions, including Urinary Incontinence (UI).  In 2016, a large epidemiology 
study in the USA1 showed prevalence in UI of 19-26% and increasing with age; this was 
most apparent for urgency urinary incontinence (UUI) and mixed urinary incontinence (MUI). 
Interestingly, the prevalence of stress urinary incontinence (SUI) did not seem to increase 
with age in this study.  
UI is associated with a negative impact on a woman’s social, physical and 
psychological wellbeing, leading to embarrassment, low self-esteem, and negative effects on 
the productivity of working women. In extreme cases, patients reported avoiding employment; 
60% avoided going away from home, and 50% avoided sexual activity2. Women with MUI 
are twice as likely to be bothered by their symptoms as compared to those with SUI alone3. 
Management of women with MUI is relatively more difficult, as it involves addressing 
both the SUI and overactive bladder (OAB) symptoms. Conservative management is usually 
the first line, including pelvic floor muscle training, bladder retraining and pharmacological 
treatment. If the above fails, surgery for SUI may be contemplated in women with 
predominant SUI symptoms; a number of options are usually discussed with the patient 
including mid-urethral slings (MUS)4. Transobturator tension-free vaginal tapes (TO-TVT) 
have been described in 2001 and 20035,6 and have rapidly gained wide popularity among 
surgeons due to the avoidance of the blind retro-pubic pathway. It was also hypothesised that 
TO-TVT could be preferred in women with MUI compared to retro-pubic tension-free 
vaginal tapes (RP-TVT) due to the more horizontal position of the tape and consequently, 
less postoperative OAB symptoms. Botros et al7 compared RP-TVT vs TO-TVT in 276 
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women; and showed significantly lower rates of de-novo urgency incontinence and/ 
worsening of pre-existing urgency with TO-TVT with no significant difference in SUI cure 
rates. However, concerns were raised on the associated risk of chronic groin pain with TO-
TVT.  
There is a paucity of data on the long-term outcomes of TO-TVT. In the UK, the 
National Institute for Health and Clinical Excellence (NICE), the Cochrane review in 2015, 
and most recently the European review (SCENIHR) on surgical meshes in urogynaecological 
surgery4,8,9 have all highlighted the lack of long-term outcomes data for MUS in general and 
TO-TVT in particular. They emphasized the importance of directing future research to 
address this significant gap in the literature. This study helps to bridge this gap in the 
literature, and follows up on the previously reported 1-year and 3-year outcomes of women 
with MUI from the E-TOT study10,11. 
 
Materials and Methods  
This is a secondary analysis of the E-TOT study, a prospective single-blinded 
randomised controlled trial performed in the period of April 2005 and April 2007. A total of 
341 women were recruited and randomly assigned to undergo either TVT-OTM (Ethicon Inc., 
Somerville, NJ, USA) for the Inside-out approach or TOT-ARIS® (Coloplast Corp., 
Minneapolis, MN, USA) for the Outside-in approach. The procedures were performed as 
originally described5,6 under general anaesthesia. Eighty-three women were identified to have 
pre-operative urodynamic MUI with predominant SUI symptoms and are the basis of this 
analysis as one single cohort. It is our routine clinical practice that women with MUI would 
have their OAB symptoms controlled/improved on conservative/pharmacological treatment 
before embarking on surgical treatment of SUI; women would then been given the option to 
discontinue treatment at time of surgery to monitor the response. Exclusion criteria included 
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concomitant surgery, refractory OAB symptoms, advanced pelvic organ prolapse (≥ stage 2), 
and neurological conditions such as multiple sclerosis. Randomisation and allocation 
concealment were previously described10,11. Ethical approval was obtained from South 
Glasgow Research Ethics Committee for this long-term follow-up. 
Pre-operative assessment included a detailed history, pelvic examination, and 
urodynamic assessment. Patients completed a set of validated questionnaires that included the 
King’s Health Questionnaire (KHQ), Birmingham Bowel and Urinary Symptom 
Questionnaire-22 (BBUSQ-22), and Pelvic Organ Prolapse/Incontinence Sexual Function 
Questionnaire (PISQ-12)12-14. At one, three and nine years follow-up, women completed the 
above questionnaires and in addition, the Patient Global Impression of Improvement (PGI-I)15, 
the International Consultation on Incontinence Questionnaire–Short form (ICIQ-SF)16 and 
questions on further continence surgery and adverse events.  
Outcome measures: The primary outcome measured was the patient-reported success 
rate defined as “very much improved” or “much improved” on the PGI-I, with all the other 
five responses classified as unsuccessful. In addition, all women who received further 
continence surgery were considered as failures. Secondary outcomes included improvement 
in quality of life (QoL) (≥18 points improvement in KHQ score) 17, impact on sexual function 
(change in PISQ-12 score), impact on pre-operative urgency and urgency incontinence (cure 
was defined as ≥2 point improvement on the relevant BBUSQ-22 questions) and late adverse 
events such as groin/thigh pain and mesh erosions. 
Statistical analysis was performed using SPSS version 23. Chi-squared or Fisher’s 
exact tests were used to compare categorical variables. Within-group comparisons of KHQ 
scores and PISQ-12 scores were analysed using the Wilcoxon signed rank test while 
between-group comparisons were analysed using the Mann-Whitney U test. The results of the 
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PGI-I at 9-year follow-up were compared to that of 3-year and 1-year follow-ups using 
McNemar’s test, at the Bonferroni corrected significant level of 0.025. All other statistical 
analyses were performed at a 5% significance level. Intention-to-treat (ITT) analysis will be 
presented for the primary outcome with/ without considering women who underwent further 
continence surgery as failures. Multiple sensitivity analyses were performed for those who 
were lost to follow-up.  
 
Results  
Eighty-three women with pre-operative urodynamic MUI and predominant SUI 
symptoms were randomised; 7 women were excluded (deceased n=2 and withdrawn n=5); 48 
women completed the follow-up at nine years (Outside-in n=29 vs. Inside-out n=19); 
adjusted response rate of 63% (Figure 1). The baseline characteristics of the patients with 
MUI are presented in Table 1. 
Patient-reported success rate: On considering women who had further continence 
surgery as failures, the corrected patient-reported success rate was 64.6% with a further 14.6% 
(n=7) who reported “improved”. There was no significant difference between groups 
(Outside-in 65.5% vs Inside-out 63.2%, OR 1.11, 95% CI 0.33 to 3.70, p>0.999) (Table 2). A 
sensitivity analysis was performed assuming the women lost to follow-up as failures, as 
successes, and based on their last observation carried forward (LOCF) and is presented in 
Table 2. 
There was a trend towards a drop in the patient-reported success rate over the years 
(Figure 2). Comparison of the patient-reported success, and using Bonferroni corrected 
significance level of p≤0.025 showed insignificant reduction with time: 1 vs 9 years 74.7% vs. 
64.6%; p=0.031, and 3 vs 9 years were 73.8% vs. 64.6%; p=0.039. The patient-reported 
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success rate in women with MUI was not significantly different compared to women with 
pure urodynamic SUI in the same cohort 18(64.6% vs 73.8%, OR 0.65, 95% CI 0.33, 1.29, 
p=0.273).  
Impact on OAB symptoms: At the 9-year follow-up, 46 and 44 women responded to 
the BBUQ-22 questions on urgency & UUI respectively.   Compared to baseline; 34.8% 
(n=16) were cured of urgency, while 58.7% (n=27) had persistent urgency, and 6.5% (n=3) 
had worsening urgency. 40.9% (n=18) were cured of UUI, while 56.8% (n=25) had persistent 
UUI, and 2.3% (n=1) had worsening UUI. There was no association between the type of TO-
TVT procedure and the impact on urgency (p=0.629) or on UUI (p=0.360) symptoms. There 
was a trend towards a drop in the OAB cure rates over the 9-years (Figure 2). Women with 
cured Urgency had significantly higher patient-reported success rate compared to those with 
persistent/worsened symptoms (87.5% vs. 50%, p=0.029).   
Late adverse events: Chronic groin/ leg pain was reported in one patient (2%) at nine 
years in the Outside-in group. There were no reports of mesh extrusion or erosion in this 
group. 
Impact on QoL: Thirty-four women (70.8%) completed the KHQ questionnaires at 9-
year follow-up. There were statistically significant decreases (improvement) in scores from 
baseline in all domains of the KHQ, with the exception of general health (Table 3). Clinically 
significant improvement in QoL (≥18 point improvement in total KHQ score) was found in 
85.3% (Outside-in 86.4% vs Inside-out 83.3%; OR 0.79; 95%CI 0.11, 5.53; p>0.999). 
However, based on an improvement score of ≥10 point improvement19, 91.2% had a 
clinically significant improvement in QoL (Outside-in 90.9% vs Inside-out 91.7%, OR 1.10; 
95% CI 0.09, 13.55; p>0.999). 
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Impact on sexual function: Twenty-one women (43.8%) were sexually active and 
completed the PISQ-12 sexual function questionnaire at the 9-year follow-up, however only 
16 were sexually active at both baseline and 9-year follow-up time points. 62.5% (n=10) 
showed an increase of ≥1 point in PISQ-12 scores, indicating an improvement of sexual 
function (Table 3).  
 
Discussion: 
This is the longest follow-up study reporting on the long-term outcomes of TO-TVT on 
women with MUI. Results showed patient-reported success rate of 64.6% at median of 9-
years follow-up with further 14.6% reporting improvement. It was reassuring to see that the 
results did not change significantly on sensitivity analysis using last observation carried 
forward. In-addition, 85.3% of women reported clinically significant improvement in their 
QoL which gives us more confidence in the results. It was reassuring to see that 34.8% of 
women were cured of their pre-operative urgency and 40.9% were cured of UUI, while a 
small proportion (6.5% and 2.3%) had worsening symptoms respectively; women with cured 
OAB symptoms had significantly higher patient-reported success rate on PGI-I.  
Our patient-reported success rate was comparable to other studies in the literature 
reporting on long-term outcomes of TO-TVT. Costantini et al20 compared TO-TVT vs RP-
TVT in an RCT; 31 women (66%) in the TO-TVT group had baseline MUI and showed 
patient-reported success rates of 77.4% and 64.5% at three and six years respectively. 
Similarly, Zhang et al. reported the 7-year outcomes in their RCT comparing RP-TVT vs. 
TO-TVT procedures in women with SUI; the success rate for the TO-TVT was 69.4%21, 
however they did not report the success rate in the subgroup of women with MUI. Heinonen 
et al22 assessed 139 women who underwent Outside-in TO-TVT with a mean follow-up of 6.5 
years; 76% of women with baseline MUI reported satisfaction with their surgical outcomes.  
Page 10 of 21                                E-TOT MUI V0.8 - Updated 
 
Secondary outcomes in our study were between-group comparisons. Our results showed 
no significant difference between the Outside-in and Inside-out TO-TVT; this pertained on 
multiple sensitivity analyses. These results are unique as there are no published long-term 
trials comparing these procedures in women with MUI. One retrospective study by Chun et 
al23 reported the 7-year outcomes in women with SUI and showed significantly higher 
success rates in the Outside-in group (Outside-in 95.7% vs. Inside-out 78.4%; p<0.001). 
However, the lack of randomisation and the retrospective nature allows for selection and re-
call bias respectively.  
The success rate in our study declined over the years, from 74.7% to 73.8% to 64.6% 10,11; 
the decline was not found to be statistically significant. The results are in line with the 
Cochrane review by Ford et al.8, which showed a decreasing success rate of MUS in women 
with SUI over the years. Similarly, long-term follow-up of RP-TVT vs. autologous fascial 
slings (AFS) in women with SUI showed deterioration of success at one versus ten years 
(TVT: 93% to 73% and AFS: 90% to 75.4%). However, unlike the E-TOT, the latter RCT 
used a looser definition of success  24.  
Only one systematic review and meta-analysis reported on the effectiveness of MUS in 
women with MUI. However, they only found relatively small trials that reported up to 
medium-term outcomes (mean 34.9 ± 22.9 months) 25. The authors reported that MUS are 
associated with an overall success rate of 56.4% in women with MUI and were more 
effective in treating the stress component (85-97% success) than the urgency component (28-
85% success).  
Our results showed that the majority of women still reported OAB symptoms at 9-years. 
It’s well recognized that OAB symptoms tend to wax and wane and the incidence increase 
with age26. Jahanlu and Hunskaar27 assessed 1274, originally continent, women at age of 41-
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45 years over 10 years period and showed that 40% developed new onset UI; 50%, 18.3% 
and 20.3% for stress (SUI), urgency (UUI) and mixed urinary incontinence (MUI), 
respectively. Hence on assessing urgency at long-term follow-up studies, it can be difficult to 
ascertain if it’s related to the MUS or the advancing age or is a progression of an underlying 
pathology. 
Reassuringly, 35% and 41% of women achieved our pre-defined definition of cure for 
urgency and UUI at median of 9-years respectively (≥ 2 points improvement on the urgency 
questions for the BBUQ-22). Understandably, women with cured OAB symptoms had 
significantly higher patient-reported success rates on PGI-I.  Our results were lower than Lee 
et al.28, who showed 65.5% and 63.6% resolution rate of urgency and UUI respectively at 50-
month follow-up, following Outside-in TO-TVT. In contrast, Yonguc et al. assessed 48 
women with MUI and reported that only 5.5% had resolution of UUI at 5-years follow-up29. 
Upon closer analysis, it seems that they had a stringent and unique definition of cure; a score 
of zero on the ICIQ-SF and discontinuation of anti-cholinergic medication. It is well 
recognised that ICIQ-SF has no normal values and success is usually defined by mean change 
in scores postoperatively.  
Jain et al25 described a trend of decreasing cure of OAB over time, with 81-100% cure of 
UUI component at 12 months compared to 35-43% at 38 months follow-up. Our findings 
reflect a less sharp decline: 56.2%, 51.5% and 35% at 1, 3 and 9 years respectively.  It’s 
worth noting that OAB symptoms are common and have been reported in up-to 94% of 
women with a diagnosis of urodynamic SUI, therefore OAB symptoms with urodynamic SUI 
may have different outcomes compared to those for urodynamic MUI in this study. 
Our study used the PGI-I as the primary outcome as it provides a robust, validated and 
more global review of the treatment outcome, and more fully encompassing the range of 
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benefits and potential harms of the treatment15. Several studies have established its validity 
to assess disease severity, bother and improvement after treatment in women with stress 
urinary incontinence and refractory overactive bladder. Two most recently reported 
clinical trials on 10-years outcomes following surgical treatment of SUI in women utilised 
PGI-I in their primary patient-reported outcomes30, 31. 
The long-term impact of any surgical procedure on QoL can be difficult to assess due to 
the potential development of confounding factors over the years. Nevertheless, our study used 
disease-specific questionnaires which showed clinically significant improvement in QoL in 
85% of respondents at 9-year follow-up. Similar results were seen at 1-year and 3-year 
follow-ups. Comparisons of improvement of QoL with the available literature proved 
difficult due to the differences in methods of assessing QoL by various studies. However, the 
Cochrane review8 reported that all included studies reported an improvement in womens’ 
QoL following TO-TVTs.  
Our results on the sexual function assessment are unlikely to be of clinical significance, 
knowing the small number of women in this analysis. Nevertheless, Zhang et al.21 reported 
similar results with no significant improvement in sexual function after a mean of 95 months 
following TO-TVT operation.  
 
Strengths and limitations 
This study has a number of strengths: the longest reported follow-up on women with MUI; 
the follow-up by postal questionnaire eliminates the risk of detection bias;  and the use of 
validated questionnaires for assessing the outcomes. However, we acknowledge the 
limitations of the results; one of which is the sizeable loss to follow-up despite attempts to 
minimise attrition. As a secondary analysis of a larger RCT, the sample size was not 
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adequately powered to detect a difference between the two types of TO-TVT procedures and 
leaves it vulnerable to a type II error. Nevertheless, the results will be quite important for 
relevant meta-analyses. The lack of objective assessment can be seen as a limitation; however 
the research community is increasingly recognising patient-reported outcome measures as 
more clinically relevant32. 
 
Conclusion 
This is the first study to report the long-term outcomes of TO-TVT in women with 
urodynamic MUI; TO-TVT operations are associated with a good and sustained patient-
reported success rate in women with MUI, up to nine years of follow-up. 40% of women 
were cured of urgency incontinence. 
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Figure 1: CONSORT diagram of patients recruited and follow-up 
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Figure 2: PGI-I success rate and OAB outcomes at 1, 3 and 9-year follow-up 
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Table 1: Baseline characteristics of patients 
 Whole cohort Outside-in Inside-out p-value 
Median age (IQR)  52.00  
(46.47 to 67.57) 
55.70 
(47.52 to 66.73) 
47.37 
(44.73 to 68.51) 
0.287 
Mean BMI ± SD 28.65 ± 4.706 28.97 ± 5.130 28.16 ± 4.059 0.567 
Previous anti-
muscarinics 
12/48 
(25.0%) 
8/29 
(27.6%) 
4/19 
(21.1%) 
0.865 
Previous 
hysterectomy 
21/48 
(43.8%) 
14/29 
(48.3%) 
7/19 
(36.8%) 
0.629 
Previous anterior 
repair 
4/48 
(8.3%) 
1/29 
(3.4%) 
3/19 
(15.8%) 
0.286 
Previous 
incontinence 
surgery 
6/48 
(12.5%) 
3/29 
(10.3%) 
3/19 
(15.8%) 
0.669 
 
 
Table 2: Patient-reported success at 9-year follow-up 
 Total number 
(%) 
Outside-in 
(%) 
Inside-out 
(%) 
OR (95% CI) p-value 
PGI-I # 31/48 (64.6) 19/29 (65.5) 12/19 (63.2) 1.11 (0.33, 3.70) >0.999 
Sensitivity analysis based on PGI-I # for patients lost to follow-up: 
Last observation carried 
forward  
47/77 (61.8) 26/42 (63.4) 21/35 (60.0) 1.16 (0.46, 2.92) 0.945 
Assume all missing data 
as failure  
31/83 (37.3) 19/42 (45.2) 12/41 (29.3) 2.00 (0.81, 4.94) 0.202 
Assume all missing data 
as success 
66/83 (79.5) 32/42 (76.2) 34/41 (82.9) 0.66 (0.22, 1.94) 0.625 
 
 PGI-I success defined as “very much” or “much improved” 
# ITT analysis considering women who had further continence surgery as failures  
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Table 3: Comparison of KHQ and PISQ-12 scores between pre-operative and 9-year 
follow-up and between Outside-in and Inside-out procedures  
 Median (IQR) p-value Median difference (IQR) p-
value Pre-op 9-year post-op Outside-in Inside-out 
KHQ 
domains 
General 
health 
25.00  
(25.00 , 25.00) 
25.00  
(0.00 , 50.00) 
0.297 0.00  
(0.00 , 18.75) 
0.00  
(-25.00 , 0.00) 
0.117 
Incontinence 
impact 
100.00  
(66.67 , 100) 
33.33  
(0.00 , 66.67) 
<0.001 66.67  
(33.33 , 91.67) 
66.67  
(25.00 , 100.00) 
0.944 
Role 
limitation 
83.33  
(50.00 , 100.00) 
0.00  
(0.00 , 33.33) 
<0.001 66.67  
(33.33 , 83.33) 
66.67  
(25.00 , 83.33) 
>0.99
9 
Physical 
limitation 
66.67  
(50.00 , 95.83) 
16.67  
(0.00 , 33.33) 
<0.001 50.00  
(16.67 , 66.67) 
50.00  
(25.00 , 83.33) 
0.325 
Social 
limitation 
50.00  
(22.22 , 77.78) 
0.00  
(0.00 , 22.22) 
<0.001 22.22  
(0.00 , 63.89) 
55.56  
(19.44 , 75.00) 
0.303 
Personal 
limitation 
33.33  
(0.00 , 83.33) 
0.00  
(0.00 , 0.00) 
0.001 16.67  
(0.00 , 66.67) 
33.33  
(0.00 , 58.33) 
0.602 
Emotions 66.67  
(44.44 , 100.00) 
0.00  
(0.00 , 27.78) 
<0.001 44.44  
(33.33 , 75.00) 
44.44  
(33.33 , 83.33) 
0.464 
Sleep/ 
energy 
66.67  
(37.50 , 83.33) 
25.00  
(0.00 , 50.00) 
<0.001 33.33  
(0.00 , 50.00) 
33.33  
(16.67 , 50.00) 
0.941 
Severity 
measure 
83.33  
(66.67 , 91.67) 
25.00  
(2.08 , 50.00) 
<0.001 58.33  
(27.08 , 68.75) 
54.17  
(16.67 , 70.83) 
0.966 
Total KHQ 63.43  
(50.15 , 78.24) 
17.28  
(4.24 , 26.85) 
<0.001 43.98  
(25.89 , 63.27) 
50.20  
(23.46 , 57.48) 
0.885 
Total PISQ-12 28.5  
(22.00 , 33.00) 
35.00  
(29.00 , 40.50) 
0.093 7.50  
(-0.75 , 14.75) 
-1.00  
(-4.25 , 8.75) 
0.301 
 
 
 
